Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)
CNY 13.33
(-0.22%)
CNY 13.33
(-0.22%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.03 Billion CNY | 12.17% |
| 2022 | 921.17 Million CNY | 45.32% |
| 2021 | 633.9 Million CNY | 66.56% |
| 2020 | 380.58 Million CNY | 60.05% |
| 2019 | 237.79 Million CNY | 51.32% |
| 2018 | 157.14 Million CNY | 6.46% |
| 2017 | 147.6 Million CNY | 32.4% |
| 2016 | 111.48 Million CNY | -44.28% |
| 2015 | 200.07 Million CNY | 50.12% |
| 2014 | 133.27 Million CNY | -19.83% |
| 2013 | 166.24 Million CNY | 22.01% |
| 2012 | 136.25 Million CNY | 16.41% |
| 2011 | 117.04 Million CNY | 6.54% |
| 2010 | 109.85 Million CNY | 63.45% |
| 2009 | 67.21 Million CNY | 62.25% |
| 2008 | 41.42 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 238.22 Million CNY | 0.62% |
| 2024 Q3 | 155.88 Million CNY | -34.56% |
| 2024 Q1 | 236.75 Million CNY | 256.11% |
| 2023 Q2 | 341.03 Million CNY | 21.5% |
| 2023 FY | 1.03 Billion CNY | 12.17% |
| 2023 Q3 | 345.04 Million CNY | 1.18% |
| 2023 Q4 | 66.48 Million CNY | -80.73% |
| 2023 Q1 | 280.69 Million CNY | 57.97% |
| 2022 Q1 | 207.81 Million CNY | 29.25% |
| 2022 FY | 921.17 Million CNY | 45.32% |
| 2022 Q4 | 177.69 Million CNY | -35.42% |
| 2022 Q3 | 275.16 Million CNY | 5.73% |
| 2022 Q2 | 260.25 Million CNY | 25.24% |
| 2021 Q2 | 180.43 Million CNY | 91.13% |
| 2021 FY | 633.9 Million CNY | 66.56% |
| 2021 Q3 | 198.28 Million CNY | 9.89% |
| 2021 Q4 | 160.77 Million CNY | -18.92% |
| 2021 Q1 | 94.4 Million CNY | -33.15% |
| 2020 Q1 | 32.45 Million CNY | -68.22% |
| 2020 Q3 | 109.92 Million CNY | 13.32% |
| 2020 Q4 | 141.21 Million CNY | 28.47% |
| 2020 FY | 380.58 Million CNY | 60.05% |
| 2020 Q2 | 96.99 Million CNY | 198.91% |
| 2019 Q1 | 43.43 Million CNY | -30.4% |
| 2019 FY | 237.79 Million CNY | 51.32% |
| 2019 Q4 | 102.1 Million CNY | 207.87% |
| 2019 Q3 | 33.16 Million CNY | -43.87% |
| 2019 Q2 | 59.08 Million CNY | 36.05% |
| 2018 Q1 | 51.59 Million CNY | 53.17% |
| 2018 FY | 157.14 Million CNY | 6.46% |
| 2018 Q4 | 62.4 Million CNY | 940.65% |
| 2018 Q3 | 5.99 Million CNY | -83.86% |
| 2018 Q2 | 37.15 Million CNY | -27.97% |
| 2017 Q4 | 33.68 Million CNY | -16.87% |
| 2017 Q2 | 31.2 Million CNY | -26.05% |
| 2017 Q1 | 42.2 Million CNY | 67.51% |
| 2017 Q3 | 40.51 Million CNY | 29.83% |
| 2017 FY | 147.6 Million CNY | 32.4% |
| 2016 Q1 | 37.87 Million CNY | 21.36% |
| 2016 FY | 111.48 Million CNY | -44.28% |
| 2016 Q4 | 25.19 Million CNY | -47.78% |
| 2016 Q3 | 48.24 Million CNY | 29079.12% |
| 2016 Q2 | 165.33 Thousand CNY | -99.56% |
| 2015 Q2 | 71.34 Million CNY | 76.07% |
| 2015 Q1 | 40.52 Million CNY | 55.87% |
| 2015 FY | 200.07 Million CNY | 50.12% |
| 2015 Q4 | 31.21 Million CNY | -45.24% |
| 2015 Q3 | 56.99 Million CNY | -20.11% |
| 2014 Q1 | 31.72 Million CNY | -34.11% |
| 2014 FY | 133.27 Million CNY | -19.83% |
| 2014 Q2 | 43.46 Million CNY | 36.99% |
| 2014 Q4 | 25.99 Million CNY | -18.98% |
| 2014 Q3 | 32.08 Million CNY | -26.18% |
| 2013 Q3 | 31.63 Million CNY | 0.0% |
| 2013 FY | 166.24 Million CNY | 22.01% |
| 2013 Q4 | 48.15 Million CNY | 52.23% |
| 2012 FY | 136.25 Million CNY | 16.41% |
| 2011 FY | 117.04 Million CNY | 6.54% |
| 2010 FY | 109.85 Million CNY | 63.45% |
| 2009 FY | 67.21 Million CNY | 62.25% |
| 2008 FY | 41.42 Million CNY | 0.0% |